Apnimed, Inc.
APMD
IPO
$24.89
-$3.05-10.92%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 84.81M | 3.13M | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 84.81M | 3.13M | |||
| Cost of Revenue | 2.16M | 1.32M | |||
| Gross Profit | 82.65M | 1.81M | |||
| SG&A Expenses | 6.51M | 5.47M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.77M | 30.24M | |||
| Operating Income | 68.04M | -27.11M | |||
| Income Before Tax | 70.37M | -26.68M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 70.37M | -26.68M | |||
| Earnings from Discontinued Operations | -2.65M | -1.97M | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 67.72M | -28.65M | |||
| EBIT | 68.04M | -27.11M | |||
| EBITDA | 68.05M | -27.11M | |||
| EPS Basic | 12.45 | -5.33 | |||
| Normalized Basic EPS | 7.85 | -3.10 | |||
| EPS Diluted | 1.52 | -5.33 | |||
| Normalized Diluted EPS | 0.99 | -3.10 | |||
| Average Basic Shares Outstanding | 5.44M | 5.38M | |||
| Average Diluted Shares Outstanding | 43.07M | 5.38M | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||